治疗药物监测市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测F 按产品、技术、药物类别、终端用户、地区和竞争情况分类

全球治疗药物监测市场预计将在预测期内实现令人瞩目的增长。全球医疗保健行业的扩张加速了对治疗药物监测的需求。治疗药物监测是一种检测方法，通过测量血液中的几种药物来验证给药剂量是否正确。这种检测通常是为了优化某些治疗指数较窄的药物的安全性和有效性，这意味着治疗剂量和毒性剂量之间的差异相对较小。抗心律失常、抗生素、抗癫痫和精神药物都需要进行监测，以保证其有效性和安全性。治疗药物监测的目的是确保患者接受正确剂量的药物，以达到预期的治疗效果，同时将不良反应的风险降至最低。它包括在特定时间间隔测量血液中的药物浓度，并根据需要调整药物剂量，以将药物浓度维持在目标范围内。随着人们对药物的准确剂量和治疗效果的认识不断提高，以及不同药物的副作用和对患者健康的不良影响发生率的增加，预计未来几年全球治疗药物监测市场将迎来有利可图的发展机会。

研发和临床试验不断增长

对治疗药物监测 (TDM) 相关研发项目的日益关注以及药物监测测试在不同治疗领域的广泛应用也对市场产生了影响。为扩大技术在不同适应症中的应用而不断加大的研发力度和临床研究，以及癌症、神经系统疾病、艾滋病、自身免疫性疾病和心脏病发病率的上升，都为全球治疗药物监测市场的增长提供了支持。临床神经病学杂志》于 2021 年 8 月报道，癫痫影响着全球 7000 多万人，是继痴呆症和中风之后的第三大神经系统疾病。据世界卫生组织估计，截至 2021 年，全球有超过 5500 万人患有痴呆症。每年报告的新病例将接近 1 000 万例。在 60-70% 的病例中，最常见的痴呆症 - 阿尔茨海默病可能是致病因素之一。因此，预计在预测期内，这些疾病风险的上升将推动治疗药物监测市场的扩大。

治疗监控在器官移植中的应用

管理接受实体器官移植的患者需要对免疫抑制剂进行治疗药物监测。移植受者服用免疫抑制剂是为了防止机体对器官产生排斥反应。临床医生必须为每位患者量身定制免疫抑制剂药物，以便在副作用的可能性和治疗效果之间取得理想的平衡。由于患者的药效学和药代动力学各不相同，因此很难通过免疫抑制剂治疗监测来实现这一目标。

精准用药

近年来，精准医疗越来越受到关注，而治疗药物监测有望在这一方法中发挥重要作用。精准用药是指根据患者的具体特征，如遗传、年龄、体重、器官功能和伴随药物等，为患者量身定制药物剂量。治疗药物监测可帮助优化药物剂量，实现个性化治疗效果，从而在治疗药物监测实践中更多地采用精准剂量方法。这反过来又将为预测期内全球治疗药物监测市场的增长开辟新的前景。

蓬勃发展的医疗保健 IT 行业

越来越多地使用先进技术并将信息技术融入医疗保健领域，使医疗保健行业发生了革命性变化。人工智能（AI）和数据分析技术在医疗保健领域的应用呈上升趋势，治疗药物监测也不例外。人工智能算法和数据分析技术可用于分析药物浓度数据、患者特征和临床结果等大型数据集，以确定模式和趋势、优化用药策略并改进治疗药物监测实践，从而为全球治疗药物监测市场的增长创造了有利可图的机会。

近年来，数字医疗技术和远程医疗发展势头迅猛，治疗药物监测也被整合到这些平台中。智能手机应用程序或可穿戴设备等数字健康工具可实现远程监测药物浓度，从而提供更方便、更容易获得的治疗药物监测服务。远程医疗还有助于根据治疗药物监测结果进行远程会诊和剂量调整，特别是在医疗服务有限的农村或偏远地区，因此支持了全球治疗药物监测市场的增长。

最新进展

• 2021 年 1 月，Theradiag 宣布其用于生物疗法监测的四种新型 i-Tracker 检测试剂盒获得了 CE 认证。
• 2021 年 11 月，Boditech Med 在 MEDICA 2021 展会上发布了全新的一体化盒式系统和带采血管的自动免疫分析仪。
• 2022 年 5 月，怀俄明州药局和 Bamboo Health（前身为 Appriss Health 和 PatientPing）于 6 月 29 日宣布建立合作伙伴关系，为怀俄明州处方药监控计划（PDMP）提供解决方案。
• 2022 年 1 月，Seer 推出新一代蛋白质组学研究平台，可用于对人体内数以万计的蛋白质进行分类，这些蛋白质驱动着生命和疾病的生物功能。
• 2022 年 3 月，Biognosys 推出其扩展的蛋白质组学平台套件，为客户提供从早期发现到临床设置的整个研发流程中的深入生物学见解。

可定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。报告可提供以下定制选项：

公司信息

• 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 覆盖市场
  • 研究年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基准方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概述
• 主要市场细分概述
• 主要市场参与者概述
• 主要地区/国家概述
• 市场驱动因素、挑战和趋势概述

第4章：客户之声

第5章：全球治疗药物监测市场展望

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（耗材、设备、免疫分析仪、色谱与质谱检测器、临床化学分析仪）
  • 按技术（免疫测定、色谱-质谱法）
  • 按药物类别（抗癫痫药物、抗生素药物、免疫抑制剂药物、抗心律失常药物、支气管扩张药物、精神活性药物及其他）
  • 按最终用户（医院实验室、商业和私人实验室、其他）
  • 按地区
  • 按公司（2022 年）
• 产品地图
  • 按产品
  • 按技术分类
  • 按药物类别
  • 按最终用户
  • 按地区

第 6 章：北美治疗药物监测市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（耗材、设备、免疫分析仪、色谱与质谱检测器、临床化学分析仪）
  • 按技术（免疫测定、色谱-质谱法）
  • 按药物类别（抗癫痫药物、抗生素药物、免疫抑制剂药物、抗心律失常药物、支气管扩张药物、精神活性药物及其他）
  • 按最终用户（医院实验室、商业和私人实验室及其他）
  • 按国家
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲治疗药物监测市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（耗材、设备、免疫分析仪、色谱与质谱检测器、临床化学分析仪）
  • 按技术（免疫测定、色谱-质谱法）
  • 按药物类别（抗癫痫药物、抗生素药物、免疫抑制剂药物、抗心律失常药物、支气管扩张药物、精神活性药物及其他）
  • 按最终用户（医院实验室、商业和私人实验室及其他）
  • 按国家
• 欧洲：国家分析
  • 法国
  • 英国
  • 意大利
  • 德国
  • 西班牙

第 8 章 : 亚太地区治疗药物监测市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（耗材、设备、免疫分析仪、色谱与质谱检测器、临床化学分析仪）
  • 按技术（免疫测定、色谱-质谱法）
  • 按药物类别（抗癫痫药物、抗生素药物、免疫抑制剂药物、抗心律失常药物、支气管扩张药物、精神活性药物及其他）
  • 按最终用户（医院实验室、商业和私人实验室及其他）
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章 : 南美治疗药物监测市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（耗材、设备、免疫分析仪、色谱与质谱检测器、临床化学分析仪）
  • 按技术（免疫测定、色谱-质谱法）
  • 按药物类别（抗癫痫药物、抗生素药物、免疫抑制剂药物、抗心律失常药物、支气管扩张药物、精神活性药物及其他）
  • 按最终用户（医院实验室、商业和私人实验室及其他）
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲治疗药物监测市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按产品（耗材、设备、免疫分析仪、色谱与质谱检测器、临床化学分析仪）
  • 按技术（免疫测定、色谱-质谱法）
  • 按药物类别（抗癫痫药物、抗生素药物、免疫抑制剂药物、抗心律失常药物、支气管扩张药物、精神活性药物及其他）
  • 按最终用户（医院实验室、商业和私人实验室及其他）
  • 按国家
• 中东和非洲：国家分析
  • 南非治疗药物监测
  • 阿联酋 治疗药物监测
  • 沙特阿拉伯 治疗药物监测
  • 土耳其治疗药物监测
  • 埃及 治疗药物监测

第 11 章 ：市场动态

• 驱动因素
• 挑战

第 12 章 ：市场趋势与发展

• 产品发布
• 合併与收购
• 技术进步

第 13 章 ：全球治疗药物监测市场：SWOT 分析

第14章：竞争格局

• 罗氏公司
  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials (In Case of Listed Companies)
  • Key Personnel
  • SWOT Analysis
• 西门子医疗保健有限公司
• 赛默飞世尔科技公司
• Bio-Rad Laboratories, Inc.
• 贝克曼库尔特公司
• 雅培实验室公司
• 安捷伦科技公司
• 生物梅里埃公司
• Alere, Inc.

第 15 章：战略建议

Global Therapeutic Drug Monitoring Market is projected to witness impressive growth during the forecast period. The worldwide healthcare industry's expansion is accelerating the demand for therapeutic medication monitoring. Therapeutic drug monitoring is a test that measures several medications in the bloodstream to verify the correct dosage of medication being given. This is typically done to optimize the safety and effectiveness of certain medications that have a narrow therapeutic index, meaning that the difference between a therapeutic dose and a toxic dose is relatively small. Anti-arrhythmic, antibiotic, anti-epileptic, and psychotropic medications all require monitoring to guarantee their effectiveness and safety. The goal of therapeutic drug monitoring is to ensure that a patient is receiving the right dose of medication to achieve the desired therapeutic effect while minimizing the risk of adverse effects. It involves measuring drug concentrations in the blood at specific intervals and adjusting the medication dosage as needed to maintain drug levels within the target range. The growing awareness among the population pertaining to accurate dosage, and therapeutic effects of drugs coupled with increased incidences of side-effects and adverse impacts on patient health due to different medications is expected to create lucrative opportunities for the growth of global therapeutic drug monitoring market in the next few years.

The rise in demand for hospitals and medical care institutions across the globe acts as one of the major factors driving the growth of therapeutic drug monitoring market. The growing inclination for precision medicine and the significance of therapeutic drug monitoring (TDM) in organ transplant procedures both speed up market expansion. The therapeutic drug monitoring market is also positively impacted by changes in the medical sector, rising awareness, technical advancements, and a surge in pharmaceutical company investment. Additionally, the market players would benefit from increased use in the treatment of autoimmune illnesses during the projected period 2024 to 2028.

Additionally, the growing use of therapeutic drug monitoring across biologics industry and in point of care testing is further expected to support the global therapeutic drug monitoring market growth in the next few years. Biologic drugs, which are large complex molecules used to treat various conditions such as cancer, autoimmune diseases, and inflammatory disorders, are becoming increasingly important in clinical practice. Therapeutic Drug Monitoring for biologics, such as monoclonal antibodies, may involve measuring drug concentrations and anti-drug antibody levels to optimize dosing, assess treatment response, and manage immunogenicity. Similarly, Point-of-care testing (POCT), which involves performing diagnostic tests near the patient rather than sending samples to a central laboratory, is gaining popularity in clinical practice. POCT for Therapeutic Drug Monitoring may allow for more rapid and convenient monitoring of drug concentrations, enabling quicker dose adjustments and improving patient care, especially in critical care settings or resource-limited environments.

Growing Research and Development Along with Clinical Trials

The market is also influenced by the increased attention being paid to research and development projects relating to therapeutic drug monitoring (TDM) and the widespread use of the drug monitoring test in different therapeutic sectors. Increasing R&D efforts and clinical studies to broaden the use of technology in diverse indications, as well as rising rates of cancer, neurological disorders, HIV, autoimmune, and cardiac ailments, are supporting the growth of global therapeutic drug monitoring market. The Journal of Clinical Neurology reported in August 2021 that epilepsy, which affects over 70 million people globally, is the third most prevalent neurological condition after dementia and stroke. More than 55 million people are living with dementia worldwide as of 2021, estimates the WHO. Every year, there would be close to 10 million new cases reported. The most prevalent form of dementia, Alzheimer's disease, may be a factor in 60-70% of cases. Therefore, it is predicted that over the course of the projection period, rising risks of these diseases is anticipated to fuel Therapeutic Drug Monitoring market expansion.

Use of Therapeutic Monitoring in Organ Transplant

Managing patients receiving solid-organ transplants requires conducting therapeutic drug monitoring for immunosuppressive medicines. Immunosuppressants are given to transplant recipients in order to prevent organ rejection by the body. Clinicians must tailor the immunosuppressant medication they give to each patient in order to strike the ideal balance between the likelihood of side effects and the efficacy of treatment. It can be tough to accomplish this goal with immunosuppressant therapy monitoring since patients have varied pharmacodynamics and pharmacokinetics.

Precision Dosing

Precision medicine has gained increasing attention in recent years, and Therapeutic Drug Monitoring is expected to play a significant role in this approach. Precision dosing involves tailoring drug dosages to individual patients based on their specific characteristics, such as genetics, age, weight, organ function, and concomitant medications. Therapeutic Drug Monitoring can help optimize drug dosing to achieve personalized therapeutic outcomes, and hence lead to more adoption of precision dosing approaches in Therapeutic Drug Monitoring practice. This, in turn, will open new prospects for the growth of global therapeutic drug monitoring market in the forecast period.

Flourishing Healthcare IT Industry

The increasing use of advanced technologies and integration of IT into healthcare has revolutionized the healthcare industry. The use of artificial intelligence (AI) and data analytics in healthcare is on the rise, and Therapeutic Drug Monitoring is no exception. AI algorithms and data analytics techniques can be used to analyze large datasets of drug concentration data, patient characteristics, and clinical outcomes to identify patterns and trends, optimize dosing strategies, and improve Therapeutic Drug Monitoring practices, thereby creating lucrative opportunities for the growth of global therapeutic drug monitoring market.

Digital health technologies and telemedicine have gained momentum in recent years, and Therapeutic Drug Monitoring is also being integrated into these platforms. Digital health tools, such as smartphone apps or wearable devices, can enable remote monitoring of drug concentrations, allowing for more convenient and accessible Therapeutic Drug Monitoring services. Telemedicine can also facilitate remote consultations and dose adjustments based on Therapeutic Drug Monitoring results, particularly in rural or remote areas where access to healthcare may be limited, hence, supporting the growth of global therapeutic drug monitoring market.

Market Segmentation

Global Therapeutic Drug Monitoring Market is segmented based on product, technology, class of drug, end user, and region. By product, global therapeutic drug monitoring market can be segmented into consumables, equipment, immunoassay analyzers, chromatography & MS detectors, and clinical chemistry analyzers. By technology, global therapeutic drug monitoring market can be categorized into immunoassays and chromatography-mass spectrometry. Immunoassays can be further sub-segmented into Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, and Others. Chromatography-Mass Spectrometry can be split into LC-MS and GC-MS. By Class of Drug, global therapeutic drug monitoring market can be fragmented into Antiepileptic Drugs, Antibiotic Drug, Immunosuppressant Drugs, Antiarrhythmic Drug, Bronchodilator Drugs, Psychoactive Drugs, and Others. In terms of end users, global therapeutic drug monitoring market can be divided into Hospital Labs, Commercial & Private Lab, and Others. Regionally, global therapeutic drug monitoring market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Recent Developments

• In January 2021, Theradiag announced that it had received CE marking for four new i-Tracker test kits for biotherapy monitoring.
• In November 2021, Boditech Med unveiled their brand-new all-in-one cartridge system and automated immunoassay analyzer with a blood collection tube at the MEDICA 2021 trade fair.
• The Wyoming Board of Pharmacy and Bamboo Health, formerly Appriss Health and PatientPing, announced a partnership on June 29 in May 2022, to create a solution for the Wyoming Prescription Drug Monitoring Program (PDMP).
• In January 2022, Seer launched a next-generation proteomics research platform that can be used for categorizing the tens of thousands of proteins within the human body that drive the biological functions of both life and disease.
• In March 2022, Biognosys launched its expanded suite of proteomics platforms which provides its customers with deep biological insights across the entire R&D pipeline, from early-stage discovery to clinical settings.

Market players

Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux, Inc., Alere, Inc, among others, are some of the key players operating in the global therapeutic drug monitoring market.

Report Scope:

In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Therapeutic Drug Monitoring Market, By Product:

• Consumables
• Equipment
• Immunoassay Analyzers
• Chromatography & MS Detector
• Clinical Chemistry Analyzers

Global Therapeutic Drug Monitoring Market, By Technology:

• Immunoassay
  • Chemiluminescence Immunoassay
  • Colorimetric Immunoassay
  • Fluorescence
  • Immunoassay
  • Radioimmunoassay
  • Others

• Chromatography-Mass Spectrometry
  • LC-MS
  • GC-MS

Global Therapeutic Drug Monitoring Market, By Class of Drug:

• Antiepileptic Drug
• Antibiotic Drug
• Immunosuppressant Drug
• Antiarrhythmic Drug
• Bronchodilator Drug
• Psychoactive Drug
• Others

Global Therapeutic Drug Monitoring Market, By Class of Drug:

• Hospital Labs
• Commercial & Private Labs
• Others

Global Therapeutic Drug Monitoring Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • UAE
  • South Arabia
  • Saudi Africa
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Therapeutic Drug Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
  • 5.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
    • 5.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
    • 5.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
  • 5.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
  • 5.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Product Map
  • 5.3.1. By Product
  • 5.3.2. By Technology
  • 5.3.3. By Class of Drug
  • 5.3.4. By End User
  • 5.3.5. By Region

6. North America Therapeutic Drug Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
  • 6.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
    • 6.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
    • 6.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
  • 6.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
  • 6.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Therapeutic Drug Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Class of Drug
      • 6.3.1.2.4. By End- User
  • 6.3.2. Canada Therapeutic Drug Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Class of Drug
      • 6.3.2.2.4. By End- User
  • 6.3.3. Mexico Therapeutic Drug Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Class of Drug
      • 6.3.3.2.4. By End- User

7. Europe Therapeutic Drug Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
  • 7.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
    • 7.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
    • 7.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
  • 7.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
  • 7.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Therapeutic Drug Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Class of Drug
      • 7.3.1.2.4. By End- User
  • 7.3.2. United Kingdom Therapeutic Drug Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Class of Drug
      • 7.3.2.2.4. By End- User
  • 7.3.3. Italy Therapeutic Drug Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Class of Drug
      • 7.3.3.2.4. By End- User
  • 7.3.4. Germany Therapeutic Drug Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Class of Drug
      • 7.3.4.2.4. By End- User
  • 7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Class of Drug
      • 7.3.5.2.4. By End- User

8. Asia-Pacific Therapeutic Drug Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
  • 8.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
    • 8.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
    • 8.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
  • 8.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
  • 8.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Therapeutic Drug Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Class of Drug
      • 8.3.1.2.4. By End- User
  • 8.3.2. India Therapeutic Drug Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Class of Drug
      • 8.3.2.2.4. By End- User
  • 8.3.3. Japan Therapeutic Drug Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Class of Drug
      • 8.3.3.2.4. By End- User
  • 8.3.4. South Korea Therapeutic Drug Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Class of Drug
      • 8.3.4.2.4. By End- User
  • 8.3.5. Australia Therapeutic Drug Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Class of Drug
      • 8.3.5.2.4. By End- User

9. South America Therapeutic Drug Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
  • 9.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
    • 9.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
    • 9.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
  • 9.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
  • 9.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Class of Drug
      • 9.3.1.2.4. By End- User
  • 9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Class of Drug
      • 9.3.2.2.4. By End- User
  • 9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Class of Drug
      • 9.3.3.2.4. By End- User

10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
  • 10.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
    • 10.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
    • 10.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
  • 10.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
  • 10.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Class of Drug
      • 10.3.1.2.4. By End- User
  • 10.3.2. UAE Therapeutic Drug Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Class of Drug
      • 10.3.2.2.4. By End- User
  • 10.3.3. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Class of Drug
      • 10.3.3.2.4. By End- User
  • 10.3.4. Turkey Therapeutic Drug Monitoring Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Technology
      • 10.3.4.2.3. By Class of Drug
      • 10.3.4.2.4. By End- User
  • 10.3.5. Egypt Therapeutic Drug Monitoring Market Outlook
    • 10.3.5.1. Market Size & Forecast
      • 10.3.5.1.1. By Value
    • 10.3.5.2. Market Share & Forecast
      • 10.3.5.2.1. By Product
      • 10.3.5.2.2. By Technology
      • 10.3.5.2.3. By Class of Drug
      • 10.3.5.2.4. By End- User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Product Launches
• 12.2. Mergers & Acquisitions
• 12.3. Technological Advancements

13. Global Therapeutic Drug Monitoring Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Roche AG
  • 14.1.1. Business Overview
  • 14.1.2. Product Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (In Case of Listed Companies)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Siemens Healthcare GmbH
• 14.3. Thermo Fisher Scientific, Inc.
• 14.4. Bio-Rad Laboratories, Inc.
• 14.5. Beckman Coulter, Inc.
• 14.6. Abbott Laboratories, Inc.
• 14.7. Agilent Technologies, Inc.
• 14.8. bioMerieux, Inc.
• 14.9. Alere, Inc.

15. Strategic Recommendations